Research Article

Efficacy of Aromatase Inhibitors for Azoospermia Caused by AZFc Microdeletion: A Cross-Sectional Descriptive Research Study in Chinese Population

Table 1

Clinical parameters of patients with azoospermia and AZFc microdeletion before aromatase inhibitor administration.

Clinical parametersGroup A ()Group B () value
MinMaxMinMax

Age234522430.113
BMI19.3730.5617.0424.670.688
Testicular volume right (ml)2206150.065
Testicular volume left (ml)2206150.032
FSH_b (mIU/ml)1.7078.793.0756.890.155
LH_b (mIU/ml)1.2428.080.8566.310.5
PRL_b (ng/ml)0.5436.660.3936.310.728
E2_b (pg/ml)1.59142.474.0095.000.231
T_b (ng/ml)0.629.730.2315.450.671
T/E2_b (ng/pg)0.026.120.010.770.142
Duration of infertility (year)181100.298

Group A: patients with sperm detected in the semen after AI administration; Group B: patients without sperm detected in the semen after AI administration; E2_b: estradiol of patients with azoospermia and AZFc microdeletion before AI administration; T_b: total testosterone of patients with azoospermia and AZFc microdeletion before AI administration.